Market Research

The journey to healing from depression often demands more than just symptom management; it requires a deep, inner transformation that addresses the root of emotional distress. This inner healing process is crucial for those suffering from depression, as it can lead to more profound and lasting recovery. Emerging research on psychedelics, particularly psilocybin, is shedding…

MindBio Therapeutics Corp. (CSE) has recently unveiled promising durability data from its Phase 2A clinical trials, which tested MB22001, the company’s innovative self-administered, take-home microdose of Lysergic Acid Diethylamide (LSD), as a treatment for depression. This development underscores MindBio’s commitment to advancing psychedelic medicine as a viable option for mental health treatment. Positive Outcomes in…

A lot has happened the past week. Let us summarize some of the events surrounding psychedelic drug development companies and the industry as a whole. Lykos Therapeutics Cuts 75% of Staff Lykos Therapeutics announced a reorganization plan following the FDA’s rejection of its application for an MDMA-based drug intended to treat PTSD. Despite the setback,…

Jasveen Sangha, a name that has recently made headlines, is now facing serious legal consequences following the tragic death of actor Matthew Perry. Known in some circles as the “Ketamine Queen,” Sangha has been indicted for her alleged role in Perry’s overdose, a development that has shocked both fans and those aware of her activities…